| Metric | H2 FY26 | H1 FY26 | H2 FY25 |
|---|---|---|---|
| Revenue from operations | 90.7 | 25.5 | 21.8 |
| Other income | 3.0 | 0.3 | 2.4 |
| Total income | 93.7 | 25.9 | 24.2 |
| Profit before exceptional items & tax | 3.5 | 0.6 | 0.6 |
| Profit before tax | 3.5 | 0.6 | 0.6 |
| Net profit | 2.6 | 0.4 | 0.2 |
| Operating margin | 3.7% | 2.3% | 2.5% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +1200.00% |
|---|---|
| Net profit, quarter on quarter | +550.00% |
| Revenue, year on year | +316.10% |
Source
Read the filing ↗
BSE results filing, BSE: 542934. Figures extracted from the filing.
Chandra Bhagat Pharma Ltd: key numbers
- Share price
- ₹49.45
- Market cap
- ₹37.31 Cr
- Revenue (annual)
- ₹116.3 Cr
- Net profit (annual)
- ₹3.05 Cr
- P/E (TTM)
- 12.2×Sector 50.4×
- Promoter holding
- 73.02%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.